ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,22
-1,51%
Dow Jones
42 732,13
0,80%
DAX
19 906,08
-0,49%
Brent Oil
76,495
0,00%
Bitcoin
97 765,10
-0,35%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC

  6. Guided Therapeutics Inc (QB) (GTHP) Cours

Guided Therapeutics Inc (QB)

Guided Therapeutics Inc (QB) (GTHP)

USOTC
0,16
0,01695
(11,85%)
Fermé 04 Janvier 10:00PM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
0,16
Prix Achat
0,121
Prix Vente
0,1802
Volume échangé
22 365
0,141 Fourchette du Jour 0,16
0,064 Plage de 52 semaines 0,23
Cap du marché
9,762M
Clôture Veille
0,14305
Ouverture
0,15
Dernière Transaction
115
@
0.16
Dernière heure de transaction
Volume financier
US$ 3 345
VWAP
0,149545
Volume moyen (3 m)
14 269
Actions en circulation
61 015 237
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-2,67
Bénéfice par action (BPA)
-0,06
Chiffre d'affairess
98k
Bénéfice net
-3,66M

À propos de Guided Therapeutics Inc (QB)

Guided Therapeutics, Inc. is the developer of the LuViva Advanced Cervical Scan, a rapid and painless test for the early detection of disease that leads to cervical cancer. LuViva is designed to quickly eliminate false positive Pap and HPV results and discover cervical disease missed by existing tes... Guided Therapeutics, Inc. is the developer of the LuViva Advanced Cervical Scan, a rapid and painless test for the early detection of disease that leads to cervical cancer. LuViva is designed to quickly eliminate false positive Pap and HPV results and discover cervical disease missed by existing tests. LuViva works by shining light on the cervical and reading the returned light with a spectrometer. LuViva looks for chemical and physical markers of precancer. Unlike Pap and HPV tests, the device does not require a painful tissue sample and results are known immediately. For more information, visit www.guidedinc.com. Show more

Secteur
Electromedical Apparatus
Industrie
Electromedical Apparatus
Site Web
www.guidedinc.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Guided Therapeutics Inc (QB) est coté dans le secteur Electromedical Apparatus de la OTCMarkets avec le ticker GTHP. Le dernier cours de clôture d'Guided Therapeutics (QB) était de US$0,14. Au cours de la dernière année, les actions de Guided Therapeutics (QB) ont été négociées dans une fourchette de prix de US$ 0,064 à US$ 0,23.

Guided Therapeutics (QB) compte actuellement 61 015 237 actions en circulation. La capitalisation boursière d'Guided Therapeutics (QB) est de US$8,73 million. Guided Therapeutics (QB) a un ratio cours/bénéfice (ratio PE) de -2.67.

GTHP Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities

21 Décembre 2024
Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

14 Novembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

14 Novembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

25 Octobre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

24 Octobre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

02 Octobre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

09 Septembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

06 Septembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

05 Septembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

03 Septembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.023417.13030746710.13660.160.136688040.14637531CS
4-0.011-6.432748538010.1710.1750.127126550.16163378CS
12-0.0149-8.519153802170.17490.230.127142690.17059619CS
260.068574.86338797810.09150.230.0915117010.1570675CS
520.00090.5656819610310.15910.230.064201900.13063238CS
156-0.53-76.81159420290.690.77990.062174750.23785142CS
260-0.01465-8.388204981390.1746510.062160640.31353763CS

GTHP - Frequently Asked Questions (FAQ)

What is the current Guided Therapeutics (QB) share price?
The current share price of Guided Therapeutics (QB) is US$ 0,16
How many Guided Therapeutics (QB) shares are in issue?
Guided Therapeutics (QB) has 61 015 237 shares in issue
What is the market cap of Guided Therapeutics (QB)?
The market capitalisation of Guided Therapeutics (QB) is USD 8,73M
What is the 1 year trading range for Guided Therapeutics (QB) share price?
Guided Therapeutics (QB) has traded in the range of US$ 0,064 to US$ 0,23 during the past year
What is the PE ratio of Guided Therapeutics (QB)?
The price to earnings ratio of Guided Therapeutics (QB) is -2,67
What is the cash to sales ratio of Guided Therapeutics (QB)?
The cash to sales ratio of Guided Therapeutics (QB) is 100
What is the reporting currency for Guided Therapeutics (QB)?
Guided Therapeutics (QB) reports financial results in USD
What is the latest annual turnover for Guided Therapeutics (QB)?
The latest annual turnover of Guided Therapeutics (QB) is USD 98k
What is the latest annual profit for Guided Therapeutics (QB)?
The latest annual profit of Guided Therapeutics (QB) is USD -3,66M
What is the registered address of Guided Therapeutics (QB)?
The registered address for Guided Therapeutics (QB) is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Guided Therapeutics (QB) website address?
The website address for Guided Therapeutics (QB) is www.guidedinc.com
Which industry sector does Guided Therapeutics (QB) operate in?
Guided Therapeutics (QB) operates in the ELECTROMEDICAL APPARATUS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
EGIOQEdgio Inc (CE)
US$ 0,01
(999 900,00%)
584
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0,008
(799 900,00%)
477
THCBFTHC Biomed International Limited (CE)
US$ 0,001
(99 900,00%)
100
AEORFAEON REIT Investment Corporation (PK)
US$ 796,08
(26 436,00%)
1
EFTReFFECTOR Therapeutics Inc (CE)
US$ 0,0002
(19 900,00%)
225
UFABQUnique Fabricating Inc (CE)
US$ 0,000001
(-99,98%)
102,53k
VICFFVice Health and Wellness Inc (CE)
US$ 0,000001
(-99,97%)
996
SAFSSafer Shot Inc (CE)
US$ 0,000001
(-99,93%)
2,54M
ERFBERF Wireless Inc (CE)
US$ 0,0001
(-99,89%)
99,77k
ARVLFArrival (CE)
US$ 0,0002
(-99,60%)
42,86k
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0,0038
(52,00%)
608,97M
HMBLHUMBL Inc (PK)
US$ 0,0009
(0,00%)
546,25M
PHILPHI Group Inc (PK)
US$ 0,0003
(0,00%)
501,07M
CBIACanopus Biopharma Inc (PK)
US$ 0,0002
(100,00%)
281,95M
RDARRaadr Inc (PK)
US$ 0,00125
(-10,71%)
169,44M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

USOTC
GTHP
Guided Therapeutics (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés